ストックスクリーナーアプリを入手
6.585
0.69%
0.045
プレマーケット:
6.07
-0.515
-7.82%
前日終値:
$6.54
開ける：
$6.53
24時間の取引高:
1.55M
Relative Volume:
1.12
時価総額：
$1.25B
収益：
$53.61M
当期純損益:
$-142.52M
株価収益率:
-5.9324
EPS:
-1.11
ネットキャッシュフロー:
$-141.83M
1週間 パフォーマンス:
-18.70%
1か月 パフォーマンス:
+7.25%
6か月 パフォーマンス:
-59.95%
1年 パフォーマンス:
+14.32%
1日の値動き範囲:
$6.40
$6.705
1週間の範囲:
$5.62
$8.23
52週間の値動き範囲:
$4.25
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
WVE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
6.585 | 1.25B | 53.61M | -142.52M | -141.83M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 開始されました | Wedbush | Outperform |
| 2025-02-25 | 開始されました | Jefferies | Buy |
| 2024-10-16 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | 再開されました | JP Morgan | Overweight |
| 2024-09-19 | 開始されました | B. Riley Securities | Buy |
| 2024-09-09 | 開始されました | JP Morgan | Overweight |
| 2024-05-15 | 開始されました | Wells Fargo | Overweight |
| 2023-12-19 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | 開始されました | Raymond James | Outperform |
| 2023-05-24 | ダウングレード | Jefferies | Buy → Hold |
| 2020-12-15 | 再開されました | H.C. Wainwright | Buy |
| 2020-10-23 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | 開始されました | Guggenheim | Buy |
| 2019-07-15 | 開始されました | Cowen | Market Perform |
| 2019-04-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-08-07 | 開始されました | Stifel | Buy |
| 2018-07-23 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-19 | 繰り返されました | Mizuho | Buy |
| 2017-02-15 | 開始されました | H.C. Wainwright | Buy |
| 2016-11-10 | 再開されました | Leerink Partners | Outperform |
| 2015-12-07 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-12-07 | 開始されました | Jefferies | Buy |
| 2015-12-07 | 開始されました | Leerink Partners | Outperform |
| 2015-12-07 | 開始されました | Sun Trust Rbsn Humphrey | Buy |
すべてを表示
Wave Life Sciences Ltd (WVE) 最新ニュース
Despite shrinking by US$215m in the past week, Wave Life Sciences (NASDAQ:WVE) shareholders are still up 407% over 3 years - simplywall.st
RBC Cuts Price Target on Wave Life Sciences to $9 From $10, Keeps Sector Perform, Speculative Risk - marketscreener.com
Wave Life Sciences Reports Q1 2025 Financials and Progress - TipRanks
Wave Life Sciences: Q1 Earnings Snapshot - New Haven Register
WAVE Life Sciences Ltd (WVE) Q1 2025 Earnings Call Highlights: Clinical Advancements and ... - Yahoo Finance
Wave Life Sciences (NASDAQ:WVE) Shares Gap Down Following Weak Earnings - Defense World
Decoding WAVE Life Sciences Ltd (WVE): A Strategic SWOT Insight - GuruFocus
Transcript : Wave Life Sciences Ltd., Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Wave Life Sciences Ltd earnings missed by $0.04, revenue fell short of estimates - Investing.com Nigeria
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update | WVE Stock News - GuruFocus
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Wave Life Sciences (WVE) Misses Revenue Estimates, Advances Clinical Trials | WVE Stock News - GuruFocus
Wave Life Sciences Reports Q1 2025 Financial Results - TipRanks
WAVE LIFE SCIENCES Earnings Results: $WVE Reports Quarterly Earnings - Nasdaq
Wave Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Earnings Flash (WVE) Wave Life Sciences Reports Q1 Revenue $9.2M, vs. FactSet Est of $11.9M - marketscreener.com
WAVE Life Sciences Ltd (WVE) Q1 2025: Everything You Need To Kno - GuruFocus
WAVE Life Sciences Earnings Preview - Nasdaq
WAVE Life Sciences Ltd (WVE) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Closing Figures: Wave Life Sciences Ltd (WVE)’s Negative Finish at 6.41, Down -17.08 - DWinneX
Wave Life Sciences (WVE) Projected to Post Earnings on Thursday - Defense World
Envestnet Asset Management Inc. Acquires 12,724 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Renaissance Technologies LLC Lowers Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Invesco Ltd. Increases Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wells Fargo & Company MN Purchases 22,873 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
WVE Shares Experience Surge in Value - knoxdaily.com
Cantor Fitzgerald Predicts WVE FY2025 Earnings - Defense World
Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Wave Life Sciences to Host Webcast for First Quarter 2025 Financial Results and Business Updates - Nasdaq
Wave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025 - GlobeNewswire
RNA Medicine Pioneer Wave Life Sciences Sets Q1 2025 Earnings Call for May 8 - Stock Titan
Cantor Fitzgerald Initiates Coverage on Wave Life Sciences (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd (WVE) Stock: From Low to High in 52 Weeks - investchronicle.com
Wave Life Sciences Ltd (NASDAQ: WVE): Why Investors Shouldn’t Ditch WVE Stock In 2025 - Marketing Sentinel
The Analyst Verdict: WAVE Life Sciences In The Eyes Of 4 Experts - Benzinga
Wave Life Sciences Ltd (WVE) looking to reclaim success with recent performance - Sete News
Cantor Fitzgerald sets WAVE Life Sciences stock at Overweight By Investing.com - Investing.com India
Cantor Fitzgerald Initiates Wave Life Sciences at Overweight With $10 Price Target - marketscreener.com
Wave Life Sciences (WVE) Receives Overweight Rating and $10 Pric - GuruFocus
Wedbush analysts initates an Outperform rating for Wave Life Sciences Ltd (WVE) - knoxdaily.com
Can you now get a good deal on Wave Life Sciences Ltd’s shares? - uspostnews.com
Duchenne Muscular Dystrophy Treatment Market Growth, Trends & - openPR.com
Check Out Wave Life Sciences Ltd (WVE)’s Trade Data Rather Than the Analysts’ Views - Sete News
Analysts Say Wave Life Sciences Ltd (NASDAQ:WVE) Can Really Get To 36 In 12 Months - Marketing Sentinel
A stock that deserves closer examination: Wave Life Sciences Ltd (WVE) - uspostnews.com
Daily Market Movement: Wave Life Sciences Ltd (WVE) Sees a 3.51 Increase, Closing at 6.79 - DWinneX
Russell Investments Group Ltd. Purchases 43,398 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Wave Life Sciences Ltd (WVE) rating initates by Wedbush - knoxdaily.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of “Buy” by Brokerages - Defense World
(WVE) Investment Report - news.stocktradersdaily.com
Wave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Update - Defense World
Wave Life Sciences Ltd (WVE) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):